Steris PLC Form 4 insider transactions

Mary Clare Fraser, SVP & Chief HRO of STERIS plc, reports acquisition of shares and options.

Mary Clare Fraser, SVP & Chief HRO of STERIS plc, reports the withholding of 236 ordinary shares to cover tax obligations upon the vesting of restricted shares.

Cary L. Majors, SVP and President, Healthcare at STERIS plc, reports the withholding of shares to cover tax obligations following the vesting of restricted shares.

John Adam Zangerle, a Senior VP at STERIS plc, reported disposing of shares to cover tax obligations related to vesting restricted stock.

Michael Tokich, CFO of STERIS plc, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock awards.

Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, reports the withholding of shares to cover tax obligations upon the vesting of restricted shares.

Senior VP of Life Sciences at STERIS plc, Julia Madsen, reports the withholding of shares to cover tax obligations following the vesting of restricted stock awards.

Kenneth Kohler, SVP & GM at STERIS plc, reports the withholding of shares to cover tax obligations upon the vesting of restricted shares.

Daniel Carestio, President and CEO of STERIS plc, disposed of shares to cover tax obligations related to vesting restricted stock units.

Karen L. Burton, VP & CAO of STERIS plc, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock awards.

Kenneth Kohler, SVP & GM at STERIS plc, reports the withholding of 112 shares for tax obligations following the vesting of restricted shares.

John Adam Zangerle, Sr. VP, Gen Counsel, and Sec. of STERIS plc, reports the withholding of 346 shares for tax obligations following the vesting of restricted shares.

Michael Tokich, Sr. Vice President and CFO of STERIS plc, reports the withholding of 580 shares for tax obligations following the vesting of restricted shares.

STERIS plc's V.P. & Corporate Treasurer, Renato Tamaro, reports the withholding of 72 shares for tax obligations following the vesting of restricted shares.

Senior VP Julia Madsen of STERIS plc reports the withholding of 207 shares for tax obligations following the vesting of restricted shares.

Karen L. Burton, VP & CAO of STERIS plc, reports the withholding of 102 ordinary shares to cover tax obligations related to the vesting of restricted shares.

Daniel Carestio, President and CEO of STERIS plc, reports the withholding of 1,286 shares to cover taxes on vested restricted shares.

Andrew Xilas, SVP and GM of Dental at STERIS plc, reports the withholding of 124 shares to cover taxes upon vesting of restricted shares on May 31, 2024.

Director Richard C. Breeden exercised stock options to acquire 4,584 ordinary shares of STERIS plc at a price of $51.53 on May 21, 2024.

Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, exercised stock options and sold shares on May 16, 2024, according to a Form 4 filing with the SEC.

Director Cynthia Feldmann exercised stock options and sold shares of STERIS plc on May 15, 2024.

Michael Tokich, CFO of STERIS plc, exercised stock options and sold shares on May 15, 2024, according to a Form 4 filing with the SEC.

Director Mohsen Sohi exercised stock options and sold STERIS plc shares on May 14, 2024, according to a Form 4 filing with the SEC.

Karen L. Burton, VP & CAO of STERIS plc, reported the sale of 3,000 ordinary shares at a price of $235.95 on May 14, 2024, leaving her with 3,759 shares.

Director Jacqueline B Kosecoff exercised stock options and sold shares of STERIS plc on May 13, 2024.

Cary L. Majors, SVP and President, Healthcare at STERIS plc, sold 2,024 ordinary shares of the company on May 13, 2024, at a weighted average price of $232.13 per share.